Chronic Inflammatory Demyelinating Polyradiculoneuropaty: Post-Pandemic Review
Chronic inflammatory demyelinating poly(radiculo)neuropathy is an acquired and disabling peripheral nervous system disease in which the immune system plays a role in a chronic process. Although the disease has been known for many years, its first serious definition was made by James Austin in 1958 and it was reported that the disease progressed with recurrences, responded to corticosteroid therapy and that the underlying cause of this clinic may be segmental demyelinization. In this article, in the light of the new information obtained about the pathophysiology and treatment of the disease, it is aimed to review the changes in treatment strategies after the coronavirus pandemic in 2019 (COVID-19) and the update of the electrophysiological diagnostic criteria of the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) in 2021..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Boğaziçi Tıp Dergisi - 10(2023), 3, Seite 196-202 |
| Sprache: |
Englisch ; Türkisch |
|---|
| Beteiligte Personen: |
Hilal Taştekin Toz [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Chronic inflammatory demyelinating polyneuropathy |
|---|
| doi: |
10.14744/bmj.2023.48278 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ10026364X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ10026364X | ||
| 003 | DE-627 | ||
| 005 | 20240414090544.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240414s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.14744/bmj.2023.48278 |2 doi | |
| 035 | |a (DE-627)DOAJ10026364X | ||
| 035 | |a (DE-599)DOAJ189b1217b18448b5a117da9023ed6234 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a tur | ||
| 100 | 0 | |a Hilal Taştekin Toz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chronic Inflammatory Demyelinating Polyradiculoneuropaty: Post-Pandemic Review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Chronic inflammatory demyelinating poly(radiculo)neuropathy is an acquired and disabling peripheral nervous system disease in which the immune system plays a role in a chronic process. Although the disease has been known for many years, its first serious definition was made by James Austin in 1958 and it was reported that the disease progressed with recurrences, responded to corticosteroid therapy and that the underlying cause of this clinic may be segmental demyelinization. In this article, in the light of the new information obtained about the pathophysiology and treatment of the disease, it is aimed to review the changes in treatment strategies after the coronavirus pandemic in 2019 (COVID-19) and the update of the electrophysiological diagnostic criteria of the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) in 2021. | ||
| 650 | 4 | |a chronic inflammatory demyelinating polyneuropathy | |
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a ean/pns. | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 773 | 0 | 8 | |i In |t Boğaziçi Tıp Dergisi |d Kare Publishing, 2020 |g 10(2023), 3, Seite 196-202 |w (DE-627)DOAJ000158615 |x 21490287 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g number:3 |g pages:196-202 |
| 856 | 4 | 0 | |u https://doi.org/10.14744/bmj.2023.48278 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/189b1217b18448b5a117da9023ed6234 |z kostenfrei |
| 856 | 4 | 0 | |u https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-48278 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2149-0287 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2023 |e 3 |h 196-202 | ||